https://techcrunch.com/2021/10/11/skycell-raises-a-35-million-series-c-round-and-enters-covid-19-vaccine-distribution-market/

SkyCell, a Swiss company developing smart containers for transporting medicines and vaccines, is announcing a significant round of funding. On top of a $62 million round that closed last year, the company has now raised a $35 million Series C to improve shipping of temperature-sensitive drugs – including COVID-19 vaccines. 

The round, which is a combination of equity and debt financing, lists investors from the Middle East, including DisruptAD and (the VC arm of ADQ, an Abu Dhabi-based sovereign wealth fund), and SHUAA (a major UAE asset management and investment banking firm). The investment also includes, per the company, “China-based” and Zurich-based family offices,” and investment from Mobiliar, a major private Swiss insurance company.